Ceapro Inc
XTSX:CZO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ceapro Inc
XTSX:CZO
|
CA |
|
T
|
TAG Immobilien AG
XETRA:TEG
|
DE |
|
Kaisun Holdings Ltd
HKEX:8203
|
HK |
|
Kanzhun Ltd
NASDAQ:BZ
|
CN |
|
G
|
Guobang Pharma Ltd
SSE:605507
|
CN |
|
L
|
Life Healthcare Group Ltd
HKEX:928
|
HK |
|
R
|
Resolute Forest Products Inc
TSX:RFP
|
CA |
|
W
|
Wuxi Unicomp Technology Co Ltd
SSE:688531
|
CN |
|
T
|
Tianyu Digital Technology Dalian Group Co Ltd
SZSE:002354
|
CN |
|
G
|
GenNBio Inc
KOSDAQ:072520
|
KR |
Ceapro Inc
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
